Teva Pharmaceutical Industries Ltd

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP TEVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

143,430

Value ($000)

4,476

Weight

0.0%

2020 Q1 - 2025 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	4,476	0.0%	143,430	12/31/2025
2024 Q4	2/12/2025	154,069	0.1%	6,990,407	12/31/2024
2024 Q3	11/14/2024	72,240	0.1%	14,897,625	9/30/2024
2024 Q2	8/14/2024	94,291	0.1%	5,802,519	6/30/2024
2024 Q1	5/15/2024	17,390	0.0%	1,232,433	3/31/2024
2023 Q4	2/14/2024	41,788	0.0%	4,002,656	12/31/2023
2023 Q3	11/14/2023	40,249	0.0%	3,945,950	9/30/2023
2022 Q4	2/14/2023	333	0.0%	36,489	12/31/2022
2022 Q3	11/14/2022	13,623	0.0%	1,688,155	9/30/2022
2022 Q2	8/15/2022	18,739	0.0%	2,491,943	6/30/2022
2022 Q1	5/13/2022	19,047	0.0%	2,028,487	3/31/2022
2021 Q4	2/14/2022	1,542	0.0%	192,535	12/31/2021
2020 Q4	2/12/2021	8,051	0.0%	834,320	12/31/2020
2020 Q3	11/12/2020	30,632	0.0%	3,399,807	9/30/2020
2020 Q2	8/12/2020	60,151	0.1%	4,878,437	6/30/2020
2020 Q1	5/15/2020	23,882	0.1%	2,659,454	3/31/2020